Thomas Kammertoens Selected Research

Thomas Kammertoens Research Topics

Disease

23	Neoplasms (Cancer) 10/2022 - 07/2003
2	Necrosis 01/2020 - 01/2011
2	Carcinogenesis 12/2013 - 10/2012
2	Lymphoma (Lymphomas) 01/2013 - 01/2012
2	Inflammation (Inflammations) 09/2009 - 11/2007
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Lymphatic Vessel Tumors 10/2022
1	Wasting Syndrome (Wasting Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Melanoma (Melanoma, Malignant) 03/2016
1	Papilloma (Papillomatosis) 12/2013
1	Fibrosarcoma 05/2013
1	Foreign-Body Reaction 05/2013
1	Carcinoma (Carcinomatosis) 05/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2012
1	Plasmacytoma 01/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2010
1	Leukemia 03/2010
1	Rheumatoid Arthritis 09/2009
1	Body Weight (Weight, Body) 09/2009
1	Asthma (Bronchial Asthma) 11/2007
1	Adenoviridae Infections (Adenovirus Infections) 06/2005
1	Infarction (Infarctions) 05/2005
1	Residual Neoplasm 05/2005
1	Hematologic Neoplasms (Hematological Malignancy) 08/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2004
1	Breast Neoplasms (Breast Cancer) 03/2004

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 10/2022 - 08/2004
6	CytokinesIBA 01/2020 - 03/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2022 - 09/2009
3	InterferonsIBA 10/2022 - 01/2012
3	Interleukin-4 (Interleukin 4)IBA 12/2013 - 03/2004
3	MethylcholanthreneIBA 12/2013 - 10/2012
3	PerforinIBA 02/2013 - 07/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 03/2016
2	Fas Ligand Protein (Fas Ligand)IBA 02/2013 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 06/2005
2	Interferon-gamma (Interferon, gamma)IBA 01/2011 - 07/2003
2	AutoantigensIBA 09/2009 - 06/2005
2	AntibodiesIBA 06/2005 - 03/2004
1	LipopolysaccharidesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	SaltsIBA 01/2019
1	Cyclin-Dependent Kinase 4IBA 03/2016
1	EpitopesIBA 03/2016
1	MART-1 AntigenIBA 03/2016
1	Interleukin-13IBA 12/2013
1	anthraceneIBA 12/2013
1	Acetates (Acetic Acid Esters)FDA Link 12/2013
1	CarcinogensIBA 05/2013
1	Ganciclovir (Cytovene)FDA LinkGeneric 05/2013
1	S100 Calcium-Binding Protein A4IBA 05/2013
1	CollagenIBA 05/2013
1	Capsules (Microcapsules)IBA 05/2013
1	Collagenases (Collagenase)FDA Link 05/2013
1	Peptides (Polypeptides)IBA 04/2013
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2013
1	OvalbuminIBA 01/2012
1	Pharmaceutical PreparationsIBA 12/2011
1	SuspensionsIBA 01/2011
1	Doxycycline (Periostat)FDA LinkGeneric 01/2011
1	Immunoglobulins (Immunoglobulin)IBA 03/2010
1	staphylococcal enterotoxin BIBA 09/2009
1	GlucocorticoidsIBA 09/2009
1	Nerve Growth Factors (Neurotrophins)IBA 11/2007
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2007
1	Interleukin-2 (IL2)IBA 08/2007
1	VimentinIBA 06/2005
1	Complementary DNA (cDNA)IBA 06/2005
1	alpha Catenin (alpha E-Catenin)IBA 06/2005
1	Immunoglobulin G (IgG)IBA 06/2005
1	Green Fluorescent ProteinsIBA 04/2005
1	Lymphotoxin-alpha (Lymphotoxin)IBA 04/2004
1	DNA VaccinesIBA 03/2004

Therapy/Procedure

6	Immunotherapy 10/2022 - 05/2005
6	Therapeutics 01/2020 - 11/2007
2	Transplantation 01/2019 - 08/2004
1	Subcutaneous Injections 05/2013
1	Drug Therapy (Chemotherapy) 03/2010
1	Homologous Transplantation 08/2004
1	Hematopoietic Stem Cell Transplantation 08/2004